10 Best Micro Cap Stocks to Buy Now

2. Lifecore Biomedical, Inc. (NASDAQ:LFCR)

Market Capitalization: $216.783 million

Lifecore Biomedical, Inc. (NASDAQ:LFCR) is a U.S.-based integrated contract development and manufacturing organization. The company specializes in the manufacturing of injectable grade sodium hyaluronate (HA), and syringes and vials for injectable products used in medical procedures, along with various services like technology development, formulation development, and stability studies. As a partner for global biopharmaceutical and biotechnology companies, Lifecore has served over 40 years in bringing innovations to the market. LFCR is one of the best micro-cap stocks.

Lifecore Biomedical, Inc. (NASDAQ:LFCR)’s participation in investor and industry conferences isn’t something that is hidden. There has been a considerable rise in the management’s references to a clear potential to capture fresh deals for not only existing drugs but also collaborations with a multinational company. One such potential is Alcon Inc., LFCR’s largest client, which seems to be past its destocking phase, ready to kick in 2027.

Just recently, the biopharma innovator announced its agreement with a non-competitive buyer for the company’s multi-purpose 10-head isolator filler. With an initial receipt of $7 million at closing, Lifecore Biomedical, Inc. (NASDAQ:LFCR) expects to receive the remaining $10 million in three tranches. The purchase and installation of a new high-speed, multi-purpose 5-head isolator filler is a step forward to double the available capacity.

According to the analysts at Fintel, while the average one-year price target for Lifecore Biomedical, Inc. (NASDAQ:LFCR) is $8, the stock price could surge to $10.50. Moreover, the EBITDA margins are expected to rise from 15% to 25%+. For investors seeking to capitalize on stocks within the rapidly growing health sector, LFCR is a decent choice.